SCHEMBL1975415

SCHEMBL1975415

CCOP(=O)(Cc1ccc(S(=O)(=O)N(CCO[Si](C)(C)C(C)(C)C)CCO[Si](C)(C)C(C)(C)C)cc1)OCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.35
LMNA P02545 4/20 0.35
HTT P42858 3/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
NPSR1 Q6W5P4 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
PKM P14618 1/20 0.34
CYP2C19 P33261 1/20 0.34
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
RXFP1 Q9HBX9 1/20 0.33
CA12 O43570 4/20 0.33
CA9 Q16790 4/20 0.33
CA1 P00915 2/20 0.33
NPY5R Q15761 1/20 0.32
BMP1 P13497 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1978010 0.80 SMN1; SMN2 (0.37) TSHRLMNAHTTRAB9ASMN1; SMN2
SCHEMBL1975417 0.76 TSHR (0.39) TSHRLMNAHTTRAB9ASMN1; SMN2
SCHEMBL1974453 0.75 POLB (0.41) TSHRLMNARAB9ASMN1; SMN2PKM
SCHEMBL7757228 0.73 ALDH1A1 (0.45) TSHRSMN1; SMN2ALDH1A1L3MBTL1VCAM1
SCHEMBL24598776 0.72 PREP (0.41) HTTCA12CA9CA1NPY5R
SCHEMBL8670594 0.71 NPY5R (0.41) TSHRLMNAKDM4EALDH1A1CA12
SCHEMBL8571742 0.71 VCAM1 (0.37) TSHRLMNAHTTRAB9ASMN1; SMN2
SCHEMBL7757769 0.70 VCAM1 (0.36) TSHRLMNAHTTRAB9ASMN1; SMN2
SCHEMBL1575569 0.69 NPY5R (0.40) TSHRCA12CA9CA1NPY5R
SCHEMBL3375825 0.68 TSHR (0.50) TSHRHTTNPSR1NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8658129-B2 Agents and methods for the imaging of myelin basic protein GENERAL ELECTRIC COMPANY (US) 2014-02-25 US disclosed
US-20110142759-A1 AGENTS AND METHODS FOR THE IMAGING OF MYELIN BASIC PROTEIN GENERAL ELECTRIC COMPANY (US) 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110142759-A1 AGENTS AND METHODS FOR THE IMAGING OF MYELIN BASIC PROTEIN MAG, PMP22, MYT1 TSHR 4269/4885LMNA 472/4885HTT 2051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.